NCT06100250

Brief Summary

In the United States (US), gay and bisexual men living with human immunodeficiency virus (HIV) bear a heavy burden of bacterial sexually transmitted infections (STIs) such as gonorrhea, chlamydia, and syphilis. It is important to diagnose and treat STIs in a timely manner to prevent health complications and reduce transmissions. The purpose of this study is to understand whether gay and bisexual men living with HIV are willing to collect and return specimens for bacterial STI testing when combined with live audio/video (AV) conferencing support.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 25, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

April 19, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 7, 2025

Completed
4 months until next milestone

Results Posted

Study results publicly available

July 1, 2025

Completed
Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

11 months

First QC Date

October 20, 2023

Results QC Date

May 28, 2025

Last Update Submit

June 12, 2025

Conditions

Keywords

Specimen CollectionAudio/Video ConferencingMotivational InterviewingSexual and Gender MinoritiesTelemedicine

Outcome Measures

Primary Outcomes (11)

  • Number of Participants That Schedule a Pre-test Session

    Up to 8 weeks after participants complete the baseline survey

  • Number of Participants That Join the Pre-test Session Within 30 Minutes of the Start Time

    Up to 8 weeks after participants complete the baseline survey

  • Number of Participants That Return Each Type of Specimen Within 6 Weeks of Box Delivery

    Up to 16 weeks after participants complete the baseline survey

  • Number of Participants That Provide Specimens of Adequate Quality for Lab Testing

    Up to 16 weeks after participants complete the baseline survey

  • Number of Participants That Schedule a Post-test Session

    Up to 24 weeks after participants complete the baseline survey

  • Number of Participants That Join the Post-test Session Within 30 Minutes of the Start Time

    Up to 24 weeks after participants complete the baseline survey

  • Overall Intervention Satisfaction

    Participants' satisfaction with the pre-test session, urine sample collection, throat swab collection, rectal swab collection, blood sample collection, and the post-test session will be assessed using six 5-point Likert items included in the satisfaction survey. Response values will be summed to obtain a total score ranging from 6-30, with higher scores indicating greater overall intervention satisfaction.

    Up to 32 weeks after participants complete the baseline survey

  • Interventionist Perceptions

    Participants' perceptions of the interventionist conducting the pre-test and the post-test sessions will be assessed using two 12-item Counselor Rating Form Short scales included in the satisfaction survey. Response values will be summed to obtain a total score ranging from 24-168, with higher scores indicating more positive interventionist perceptions.

    Up to 32 weeks after participants complete the baseline survey

  • Usability of the Pre-test and the Post-test Sessions

    Participants' usability of the pre-test and the post-test sessions will be assessed using two 4-item subscales from the Telehealth Usability Questionnaire on the quality of interactions with the interventionist during each session included in the satisfaction survey. Response values will be summed to obtain a total score ranging from 8-56, with higher scores indicating greater usability of the pre-test and the post-test sessions.

    Up to 32 weeks after participants complete the baseline survey

  • Willingness to Repeat the Intervention

    Participants' willingness to repeat the pre-test session, urine sample collection, throat swab collection, rectal swab collection, blood sample collection, and the post-test session will be assessed using six 5-point Likert items included in the satisfaction survey. Response values will be summed to obtain a total score ranging from 6-30, with higher scores indicating greater willingness to repeat the intervention.

    Up to 32 weeks after participants complete the baseline survey

  • Likelihood of Recommending the Intervention to Friends or Sex Partners

    Participants' likelihood of recommending the pre-test session, urine sample collection, throat swab collection, rectal swab collection, blood sample collection, and the post-test session to friends or sex partners will be assessed using six 5-point Likert items included in the satisfaction survey. Response values will be summed to obtain a total score ranging from 6-30, with higher scores indicating greater likelihood of recommending the intervention to friends or sex partners.

    Up to 32 weeks after participants complete the baseline survey

Secondary Outcomes (5)

  • Change in STI-related Knowledge

    Pre-intervention score (from the baseline survey); Post-intervention score (from the satisfaction survey completed up to 32 weeks after participants complete the baseline survey)

  • Likelihood of Testing for Bacterial STIs at Least Annually

    Up to 32 weeks after participants complete the baseline survey

  • Change in Self-efficacy for Specimen Self-collection

    Pre-intervention score (from the baseline survey); Post-intervention score (from the satisfaction survey completed up to 32 weeks after participants complete the baseline survey)

  • Number of Participants That Test Negative or Positive for Gonorrhea, Chlamydia, and Syphilis

    Up to 16 weeks after participants complete the baseline survey

  • Number of Participants That Initiate Treatment Within 1 Week of Receiving a Positive Test Result

    Up to 28 weeks after participants complete the baseline survey

Study Arms (1)

Telehealth intervention

EXPERIMENTAL

Participants will receive an MI-based telehealth intervention for bacterial STI screening.

Behavioral: Motivational interviewing and specimen self-collection

Interventions

Participants will be asked to attend a pre-test live AV conferencing session, collect and return a urine sample, a throat swab, a rectal swab, and a blood sample for bacterial STI testing, and attend a post-test live AV conferencing session.

Telehealth intervention

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsIndividual self-reports identifying as a man (regardless of sex assigned at birth)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individual self-reports identifying as a man (regardless of sex assigned at birth) in the eligibility screener
  • Individual self-reports residing in a US state or territory in the eligibility screener
  • Individual self-reports being physically located in a US state or territory when completing study activities in the eligibility screener
  • Individual self-reports being greater than or equal to (≥)18 years of age in the eligibility screener
  • Individual self-reports being of legal age to provide consent for research participation in the US state or territory of residence in the eligibility screener
  • Individual self-reports having been diagnosed with HIV in the eligibility screener
  • Individual self-reports having any kind of condomless sex (e.g., oral, anal) with ≥2 men in the past year in the eligibility screener
  • Individual self-reports being willing to provide contact information (full name, email address, mobile phone number, and mailing address) in the eligibility screener
  • Individual self-reports being able to participate in live AV conferencing sessions using an internet-connected device (e.g., computer, tablet, smartphone) in the eligibility screener
  • Individual self-reports being willing to receive a box that contains kits to self-collect a urine sample, a throat swab, a rectal swab, and a blood sample for bacterial STI testing in the eligibility screener
  • Individual provides valid contact information (full name, email address, mobile phone number, and mailing address) in the contact information form
  • Individual completes the baseline survey in order to receive the intervention

You may not qualify if:

  • Individual self-reports not identifying as a man (regardless of sex assigned at birth) in the eligibility screener
  • Individual self-reports not residing in a US state or territory in the eligibility screener
  • Individual self-reports not being physically located in a US state or territory when completing study activities in the eligibility screener
  • Individual self-reports not being ≥18 years of age in the eligibility screener
  • Individual self-reports not being of legal age to provide consent for research participation in the US state or territory of residence in the eligibility screener
  • Individual self-reports not having been diagnosed with HIV in the eligibility screener
  • Individual self-reports not having any kind of condomless sex (e.g., oral, anal) with ≥2 men in the past year in the eligibility screener
  • Individual self-reports not being willing to provide contact information (full name, email address, mobile phone number, and mailing address) in the eligibility screener
  • Individual self-reports not being able to participate in live AV conferencing sessions using an internet-connected device (e.g., computer, tablet, smartphone) in the eligibility screener
  • Individual self-reports not being willing to receive a box that contains kits to self-collect a urine sample, a throat swab, a rectal swab, and a blood sample for bacterial STI testing in the eligibility screener
  • Individual does not provide valid contact information (full name, email address, mobile phone number, and mailing address) in the contact information form
  • Individual does not complete the baseline survey in order to receive the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Related Publications (1)

  • Sharma A, Boyd S, Bonar EE. Feasibility and Acceptability of a Motivational Interviewing-Based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening: Protocol for a Sequential Explanatory Mixed Methods Study. JMIR Res Protoc. 2024 Aug 29;13:e64433. doi: 10.2196/64433.

MeSH Terms

Conditions

Sexually Transmitted DiseasesGonorrheaChlamydia InfectionsSyphilisCoitus

Interventions

Motivational Interviewing

Condition Hierarchy (Ancestors)

Communicable DiseasesInfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsNeisseriaceae InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesSexually Transmitted Diseases, BacterialChlamydiaceae InfectionsTreponemal InfectionsSpirochaetales InfectionsSexual BehaviorBehavior

Intervention Hierarchy (Ancestors)

Directive CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Results Point of Contact

Title
Dr. Akshay Sharma
Organization
University of Michigan

Study Officials

  • Akshay Sharma, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, University of Michigan School of Nursing

Study Record Dates

First Submitted

October 20, 2023

First Posted

October 25, 2023

Study Start

April 19, 2024

Primary Completion

March 7, 2025

Study Completion

March 7, 2025

Last Updated

July 1, 2025

Results First Posted

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

Study results will be publicly reported through presentations at domestic and international conferences, and publications in peer-reviewed journals. Once analyses relating to the major aims of the proposed study have been completed and reported, the data will be deposited with the Inter-university Consortium for Political and Social Research (ICPSR) located at the University of Michigan. All confidentiality requirements will be followed as outlined on the website. ICPSR will make the data available to over 750 universities, government agencies, and other institutions, permitting other researchers to conduct secondary analyses. Data availability will be announced on the ICPSR website.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be made available within 6 months after analyses relating to the major aims of the proposed study have been completed and reported, and will remain available for at least 5 years.
Access Criteria
Creating an account on the ICPSR website.
More information

Locations